MYM’s Joint Venture Company BioHemp Signs LOI for the Sale of $25 Million of CBD-Rich Hemp Biomass

Vancouver, British Columbia, July 23, 2019 — MYM Nutraceuticals Inc., (CSE: MYM, OTCBB: MYMMF) (“MYM” or the “Company”) is pleased to announce that its joint venture company (MYM owns 50%), BioHemp Naturals Growing & Farming Ltd. (“BioHemp”), has signed a non-binding Letter of Intent (“LOI”) for the sale of CBD-rich hemp biomass.

“I am truly excited to share that our sales team has secured a LOI for $25 million, representing nearly half of our remaining forecasted CBD-rich hemp biomass,” said Howard Steinberg, CEO of MYM. “The recipient of the biomass represents a consortium of Canada’s largest cannabis LP’s and is a great vote of confidence to the quality of BioHemp’s Canadian grown CBD-rich hemp.”

About MYM Nutraceuticals Inc.
MYM Nutraceuticals Inc. is an innovative company focused on the global growth of Cannabis and CBD-rich hemp. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) FRA:0MY) (MUN:0MY) (STU:0MY).

ON BEHALF OF THE BOARD

Howard Steinberg, CEO
MYM Nutraceuticals Inc.
www.mym.ca

Investor Relations

Billy Casselman
778-522-2261
investors@mym.ca

Twitter: @mymnutra
Facebook: @mymnutra
Instagram: @mymnutra

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The forward-looking statements in this news release are made as of the date of this news release. The Company disclaims and does not undertake any intention or obligation to revise or update such statements, exceot as required by applicable law. For a description of the risks and uncertainties facing the Company and its busines and affairs, readers should refer to the Company’s Management’s Discussion and Analysis dated April 24, 2019 (the “MD & A”) and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

Forward-looking statements may include, without limitation, statements relating to the Company’s forecasted amounts of hemp biomass; the quality of such forecasted biomass; the expected closing of the LOI with the recipient or the acquisition of complementary businesses and assets in the technology, nutraceuticals and CBD sectors.

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets) nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.